1 YEAR CD

Theater Owners
Host Teens, Teachers

Annual
Percentage
Yield

Annual percentage
rate effective as of
April8, 1994.

Penalty for early withdrawal.

Visit the Investment Specialists at

Sterling

bank
&trust

Birmingham — William Wessels
646-8787

West Bloomfield — Chris Yezbick
855-6644

Southfield — Jeffrey Thompson
355-9831

Renaissance Center — Daryl! McDade
393-4920

FDIC

INSURED

You're in the neighborhood, so...

Stop By!

CELMET
CELLULAR

Your Drive-In Cellular Specialists

4114 W. Maple
Bloomfield Hills
(810) 932-9700

Cellnet Cellular is pleased to announce the opening of
its 4th full-service location. Offering Sales, Service
and Installation of all the top cellular equipment
and accessories,
Cellnet Cellular is your 1 stop cellular shop.

Change to the new (810) area code at Cellnet and receive
FREE
bufrzff cord) through American Speedy Printing Centers:*
300

*Must sign on with Cellnet for minimum 12 month term

Advertising in The Jewish News Gets Results
Place Your Ad Today. Call 354.6060

Jerusalem (JTA) — The
Globus Group, a film produc-
tion and distribution corn-
pany best known for its
blood-and- guts action flicks,
took a more serious turn last
week when it began inviting
local teen-agers to watch
Steven Spielberg's film
Schindler's List in many of
its 30 movie theaters.
Under a new project co-
sponsored by Globus Group
and the Yad Vashem Holo-
caust Memorial, thousands
of Israeli students will have
the opportunity to see the
acclaimed film as part of
their studies.
Globus had no connection
to any facet of the film,
which was produced by Mr.
Spielberg's Amblin Enter-
tainment and distributed by
Universal Pictures.
According to the arrange-
ment, which is being finaliz-
ed with Israel's Ministry of
Education, Globus will open
its theaters to high-school
students and their teachers
several mornings a week.
Yad Vashem, which al-
ready runs an extensive
Holocaust education pro-
gram in cooperation with the
school system, is preparing
materials about the film and
the events that inspired it.
Released here at the
beginning of March,
Schindler's List recounts the
story of Oskar Schindler, a
German industrialist who
saved the lives of 1,100 Jews
during the Holocaust.
In 1973, Yad Vashem rec-
ognized Mr. Schindler as a
Righteous Gentile. He is
buried in Jerusalem, in the
Christian cemetery on the
Mount of Olives.
Though educators and
Holocaust experts here view
Schindler's List as an
excellent teaching tool, they
stress that it is just one of
many in the arsenal of Holo-
caust education.
On average, Israeli high-
school students spend
several weeks studying the
Holocaust. The curriculum
includes the study of Holo-
caust films and literature, as
well as field trips and
discussions with Holocaust
survivors.
In addition, about 1,000
Israeli teens travel to Poland
to participate in the March
of the Living, a semi-annual
gathering in which Jewish
youths from around the
world visit concentration
camps and towns and

villages once inhabited by
Jews.
Despite the high quality of
Holocaust education in
Israeli schools, "there is
always more that can be
learned," said Yad Vashem
spokeswoman Billie
Laniado.
"Even among Israelis,
there are young people who
are not close to the subject,"
she said. "They are not sur-
vivors; they are not even
children of survivors.

Indigo Stock
Is Offered

Indigo, an electronic printing
technology leader, plans to raise
between $95-105 million from
the issue of five million ordinary
shares on the New York Stock
Exchange, according to the
draft prospectus.
The company plans to issue
its shares at between $19 and
$21 per share. It hopes to issue
four million shares to U.S. in-
vestors and the remaining one
million to investors outside the
United States.
Last June, investment ty-
coon George Soros acquired 12.5
percent of Indigo's shares at a
market value of $400 million.
The shares were purchased for
$50 million. The other major
shareholder in the privately
owned company is the Landa
family, led by Indigo founder
Benny Landa.

Teva Shares
Take A Plunge

Shares in Teva plunged nine
percent in heavy trading on the
Tel Aviv Stock Exchange fol-
lowing an 8.4 percent fall in
New York.
The fall dragged down Is-
rael's main market indexes, in
which Teva has a heavy weight-
ing.
Teva's shares fell more than
20 percent in New York in a re-
cent stretch.
Traders attributed the fall
to concern that increasing com-
petition among generic firms
and from branded pharmaceu-
tical companies, whose products
generic companies copy when
their patents expire, will hit
margins and, therefore, profits.
A warning to this effect by
one of the largest U.S. generic
companies has led U.S. broker-
age houses to revise their rat-
ings on a number of generic
companies.

(=\